Skip to main content
Arctic Bioscience logo

Arctic Bioscience — Investor Relations & Filings

Ticker · ABS ISIN · NO0010859580 LEI · 549300Z2HW6I989Q2C78 OL Manufacturing
Open in API
Filings indexed 422 across all filing types
Latest filing 2023-02-13 Director's Dealing
Country NO Norway
Listing OL ABS

About Arctic Bioscience

https://arctic-bioscience.com/

Arctic Bioscience is a biotechnology company that develops and commercializes pharmaceutical and nutraceutical products derived from marine membrane lipids. The company utilizes proprietary technology to extract bioactive compounds from herring roe, sourced from sustainable, MSC-certified fisheries. Its nutraceutical product line, marketed under the brand name Romega, consists of high-DHA Omega-3 phospholipid extracts. The pharmaceutical division is focused on developing a novel drug candidate for the treatment of mild-to-moderate psoriasis, aligning with its mission to create therapies for autoimmune disorders. The company's work is supported by extensive research and development to validate the efficacy of its marine-based ingredients.

Recent filings

Filing Released Lang Actions
Arctic Bioscience - Meldepliktig handel
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Appendix 3: Notification template for notifying transactions' and details transactions conducted by a person discharging managerial responsibilities (CEO Christer L. Valderhaug) in the issuer's shares (ARCTIC BIOSCIENCE AS). The content includes details like the person's name, position, nature of the transaction ('SHARE PURCHASE'), price, volume, and date. This structure perfectly matches the definition of a Director's Dealing report, which tracks personal share transactions by company directors and executives.
2023-02-13 English
Arctic Bioscience - Mandatory notification of trade
Director's Dealing Classification · 100% confidence The document is titled "Arctic Bioscience - Mandatory notification of trade" and explicitly states that the CEO, Christer Valderhaug, bought shares. It references disclosure requirements under Regulation EU 596/2014 (MAR) article 19, which pertains to insider transactions. This directly matches the definition for Director's Dealing (DIRS), which covers reports of personal share transactions by directors and executives (insider trades). Although it mentions an 'attached notification,' the core content is the insider trade disclosure itself, making DIRS the most specific fit over a general RPA or RNS.
2023-02-13 English
Arctic Bioscience - Meldepliktig handel
Director's Dealing Classification · 99% confidence The document text is titled "Arctic Bioscience - Meldepliktig handel" (Reportable trading) and details a transaction where the CEO, Christer Valderhaug, purchased shares. It explicitly mentions MAR (Market Abuse Regulation) Article 19 and the Norwegian Securities Trading Act § 5-12, which govern insider trading disclosures. This type of filing reports personal share transactions by company directors and executives. This directly corresponds to the definition for Director's Dealing (DIRS). The document is short and reports the transaction details, not just an announcement of a report.
2023-02-13 Norwegian
Arctic Bioscience - Meldepliktig handel
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details a specific transaction (Purchase) involving a board member ('Tore Andreas Frøysa Tønseth') of the issuer ('Arctic Bioscience AS'). This perfectly matches the definition of Director's Dealing (insider trades by executives/directors).
2023-02-13 English
Arctic Bioscience - Mandatory notification of trade
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details a specific transaction (Purchase) involving a board member ('Tore Andreas Frøysa Tønseth') of the issuer ('Arctic Bioscience AS'). This perfectly matches the definition of Director's Dealing (insider trades by executives/directors).
2023-02-13 English
Arctic Bioscience - Meldepliktig handel
Director's Dealing Classification · 98% confidence The document text is titled "Arctic Bioscience - Meldepliktig handel" (Mandatory trading notification) and details a transaction where an entity closely related to a leading role (Ronja Capital II AS, where a board member is the investment director) bought shares. It explicitly mentions that this information is subject to disclosure requirements under MAR (Market Abuse Regulation) Article 19 and the Norwegian Securities Trading Act § 5-12. This content directly corresponds to reporting insider or closely associated person transactions. The most fitting category among the provided definitions is 'Director's Dealing' (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document is the notification itself, not an announcement of a report, so RPA/RNS is less specific.
2023-02-13 Norwegian

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.